Beta Drugs Limited IPO

Apply 0
Avoid 0

Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. The company has a portfolio of over 50 products which is used for the treatment of various cancer diseases.
Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company’s manufacturing unit is located at Solan, Himachal Pradesh.
Company Strengths:
1. Focus on oncology segment. Manufacture over 50 products in this segment.
2. 18 product registrations in various countries. The company is in process of making additional 12 applications for product registration in various countries.

Beta Drugs Limited IPO Stock Quote & Charts



  • Open: 78.00
  • High - Low: 79.00 - 74.10
  • Previous Close: 78.90
  • Total Traded Volume: 3200
  • Updated On: 23-Dec-2019

Objects of the Beta Drugs Limited IPO:

1. Purchase of new plant and machinery and upgradation of our existing plant and machinery. 2. Civil Construction work at existing manufacturing unit. 3. To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme certificate. 4. Working Capital requirements. 5. General Corporate Purpose.

Beta Drugs Limited IPO Details:

Open Date: Sep 29 2017
Close Date: Oct 04 2017
Total Shares: 2,296,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Fixed Price Issue IPO
Issue Size: 19.52 Cr.
Lot Size: 1600 Shares
Issue Price: ₹ 85 Per Equity Share
Listing At: NSE Emerge
Listing Date: Oct 12 2017

Promoters And Management:

Mr Vijay Kumar Batra

Lead Manager of Beta Drugs Limited IPO:

  1. Pantomath Capital Advisors Private Limited

Registrar of Beta Drugs Limited IPO:

  1. Link Intime India Private Limited

Company Address:

Beta Drugs Limited Village Nandpur Baddi 17410 Phone: 01795-236196 Email: Website:

Discussion on Beta Drugs Limited IPO:

Leave a Reply